Cost-effectiveness of a post-splenectomy registry for prevention of sepsis in the asplenic

被引:24
作者
Woolley, Ian
Jones, Penelope
Spelman, Denis
Gold, Lisa
机构
[1] Alfred Hosp, Dept Infect Dis, Prahran, Vic 3181, Australia
[2] Monash Med Ctr, Dept Infect Dis, Clayton, Vic 3168, Australia
[3] Monash Univ, Dept Med, Clayton, Vic 3168, Australia
[4] Alfred Hosp, Dept Infect Dis & Microbiol, Prahran, Vic 3181, Australia
[5] Monash Univ, Dept Epidemiol & Preventat Med, Clayton, Vic 3168, Australia
[6] La Trobe Univ, Sch Publ Hlth, Bundoora, Vic, Australia
关键词
D O I
10.1111/j.1467-842X.2006.tb00786.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Overwhelming, sometimes fatal infections represent a lifelong risk after surgical removal of the spleen, or in patients who develop hyposplenism as a consequence of illnesses. This risk may be reduced by all or a combination of vaccination, antibiotic prophylaxis and education. We aimed to determine if a registry approach to delivering these interventions would be cost effective using our own experience and published data. Method: The decision model compared a cohort of 1,000 people covered by a registry to a cohort of 1,000 people with no registry. The impact of the registry was assessed in terms of achieved rates of vaccination, chemoprophylaxis and education, consequent outcomes of overwhelming post-splenectomy infection (OPSI) and mortality (years of life lived). The cost-effectiveness of the registry compared with no registry was estimated in terms of additional cost per case of OPSI avoided and as additional cost per life year gained. Results: In the first two years, the additional cost of the registry was $152,611 per case of OPSI avoided or $205,931 per life year gained. After this initial registration period the cost-effectiveness improves over time, such that over the cohort lifetime a post-splenectomy register is associated with an additional cost of $105,159 per case of OPSI avoided or $16,113 per life year gained. Conclusion: A registry-based approach is likely to prove cost effective in terms of mortality and rates of OPSI avoided.
引用
收藏
页码:558 / 561
页数:4
相关论文
共 26 条
[1]  
*ABS, 2004, 3302255001 ABS
[2]   POLYVALENT PNEUMOCOCCAL-POLYSACCHARIDE IMMUNIZATION OF PATIENTS WITH SICKLE-CELL-ANEMIA AND PATIENTS WITH SPLENECTOMY [J].
AMMANN, AJ ;
ADDIEGO, J ;
WARA, DW ;
LUBIN, B ;
SMITH, WB ;
MENTZER, WC .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (17) :897-900
[3]   Risk of infection and death among post-splenectomy patients [J].
Bisharat, N ;
Omari, H ;
Lavi, I ;
Raz, R .
JOURNAL OF INFECTION, 2001, 43 (03) :182-186
[4]   Prevention and management of overwhelming postsplenectomy infection - An update [J].
Brigden, ML ;
Pattullo, AL .
CRITICAL CARE MEDICINE, 1999, 27 (04) :836-842
[5]  
Cavill I, 1996, BRIT MED J, V312, P430
[6]  
Childs James E., 1993, Morbidity and Mortality Weekly Report, V42, P1
[7]   Prevention and management of infections in patients without a spleen [J].
Davidson, RN ;
Wall, RA .
CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (12) :657-660
[8]   Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen [J].
Davies, JM ;
Barnes, R ;
Milligan, D .
CLINICAL MEDICINE, 2002, 2 (05) :440-443
[9]  
Drummond MF, 2005, METHODS EC EVALUATIO
[10]   Overwhelming postsplenectomy infection: is quality of patient knowledge enough for prevention? [J].
El-Alfy, MS ;
El-Sayed, MH .
HEMATOLOGY JOURNAL, 2004, 5 (01) :77-80